Taken together, this data supports our notion that loss of Rb leads to dysregulation of hypoxia-inducible transcriptional processes in prostate cancer and reinforces the shRNA LNCaP lines as appropriate models to study this paradigm. The gene discussed is RB1; the disease is prostate cancer.